Dr Nancy B Gillispie, AUD | |
375 Deer Run, Sumerco, WV 25567-9541 | |
(304) 784-2552 | |
(304) 756-3818 |
Full Name | Dr Nancy B Gillispie |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 375 Deer Run, Sumerco, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053538728 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | A0212 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Nancy B Gillispie, AUD 375 Deer Run, Sumerco, WV 25567-9541 Ph: (304) 784-2552 | Dr Nancy B Gillispie, AUD 375 Deer Run, Sumerco, WV 25567-9541 Ph: (304) 784-2552 |
News Archive
Today the American Academy of Pediatrics (AAP) released recommendations for healthy exposure to digital media in childhood, and an interactive online tool to help families achieve this.
Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.
The brain activity evoked from processing written or heard semantic information is almost identical, according to research in adults published in JNeurosci. These findings add to the understanding of how the brain processes written and oral language.
A molecular pathway known to suppress tumors appears to also be a major player in clearing cells of damaged proteins implicated in neurodegenerative diseases such as ALS and certain types of dementia, new research in roundworms and human cells suggests.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 9 days ago